Tocilizumab as an Adjuvant Therapy for Hemophagocytic Lymphohistiocytosis Associated With Visceral Leishmaniasis
- 1 September 2016
- journal article
- case report
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 23 (5) , e1193-e1196
Abstract
Leishmaniasis is important as a cause of hemophagocytic lymphohistiocytosis (HLH) and must be considered and excluded in patients with HLH because it can cause severe or even fatal complications. When HLH is present, there is a deficient downregulation of the immune response, leading to an uncontrolled inflammation. We report a case of visceral leishmaniasis-HLH where the therapy with tocilizumab, targeting interleukin 6, help to regulate the immune response for the infection of Leishmania.Keywords
This publication has 15 references indexed in Scilit:
- Tocilizumab – A novel therapy for non-organ-specific autoimmune diseasesBest Practice & Research Clinical Rheumatology, 2012
- Anti‐interleukin‐6 receptor antibody, tocilizumab, for the treatment of autoimmune diseasesFEBS Letters, 2011
- Traitement du syndrome d’activation macrophagique sévère associé à une leishmaniose viscéraleArchives de Pédiatrie, 2010
- Accelerated Control of VisceralLeishmania donovaniInfection in Interleukin-6-Deficient MiceInfection and Immunity, 2008
- Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis – Case report and systematic reviewJournal of Infection, 2008
- A microculture technique for isolating live Leishmania parasites from peripheral blood of visceral leishmaniasis patientsActa Tropica, 2007
- IL-6 and TNF-α production during active canine visceral leishmaniasisVeterinary Immunology and Immunopathology, 2007
- HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosisPediatric Blood & Cancer, 2006
- 3-D QSAR Investigations of the Inhibition ofLeishmaniamajorFarnesyl Pyrophosphate Synthase by BisphosphonatesJournal of Medicinal Chemistry, 2003
- Interleukin 6 during active visceral leishmaniasis and after treatmentClinical Immunology and Immunopathology, 1995